Q4 2022 Evaxion Biotech A/S Earnings Call Transcript
Greetings and welcome to the Evaxion Corporate Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Corey Davis. Please go ahead, sir.
Thank you, operator. Good morning in the U.S. and good afternoon in Europe. Thank you for joining us today. With me on the line today are Per Norlen, Chief Executive Officer; Bo Karmark, Chief Financial Officer; and Birgitte Rønø, Chief Scientific Officer, who will join us for Q&A. Today's call will be available for replay as indicated in our press release.
Let me quickly remind you that the following discussion contains certain statements that are considered forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Because forward-looking statements involve risks and uncertainties, they're not guarantees of future performance and actual results may differ materially from those expressed or implied by these forward-looking statements due to a variety of factors, including those risk factors
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
